risankizumab,ustekinumab
abbvie,janssen
['risan', 'ustekinumab', 'crohn']
response to risankizumab in crohn s disease patients exposed to ustekinumab small numbers and need a larger population for definitive conclusions #acg2022 
Gastroenterologist, IBD specialist @yaledigestive. A @mayoclinic alumnus. Tweets are my own.